Learn about clinical trials that are currently recruiting.

— Phase 3 NASH Study
— Phase 4 PBC Study
— Phase 2 Biliary Atresia Study


At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options.

Contact Us

For more information call: 844-782-ICPT

Corporate & U.S. Headquarters

10 Hudson Yards, 37th Floor
New York, NY 10001
T: 646-747-1000

Research & Development Headquarters

4760 Eastgate Mall
San Diego, CA 92121
T: 858-652-6800

International Headquarters

Two Pancras Square
Kings Cross, London,
T: +44 203 805 7600
Investor inquiries investors@interceptpharma.com
Job inquiries See job opportunities
Media inquiries media@interceptpharma.com
Adverse reaction reporting 1-844-782-ICPT

Medical inquiries medinfo@interceptpharma.com

Medical Information Request Form (Healthcare Professionals Only)
Partnering inquiries david.chung@interceptpharma.com
Investigator-initiated research inquiries IIR@interceptpharma.com
US Practice to Policy program inquiries us.icptpracticetopolicy@wisper-public-affairs.com
EU/Canada Practice to Policy program inquiries euca.icptpracticetopolicy@wisper-public-affairs.com
Grants inquiries grants@interceptpharma.com
All other inquiries info@interceptpharma.com

You are now leaving interceptpharma.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.

Close this window to return to Intercept Pharma’s site or click ‘Continue’ to proceed. 

You are now being redirected to Intercept's job application site, hosted by a third party.